The extravascular implantable cardioverter–defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to ...
Instead of capturing multiple components of a cardiac rhythm management device implantation with a single code, ICD-10 will force providers to code each component of the device system separately, ...
The US Food and Drug Administration has approved Medtronic's novel "extravascular" implantable cardioverter-defibrillator (Aurora EV-ICD) system, which uses a single lead implanted substernally to ...
DALLAS, March 2, 2010 — A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the ...
The rate of major complications associated with cardiac implantable electronic-device (CIED) implantation varied widely among different centers in recent data from Australia and New Zealand. The rate ...
GlobalData on MSN
AtaCor raises $75m for trial of EV-ICD system
The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback